NORWALK, Conn. — HealthPrize Technologies on Tuesday reported that its medication adherence solution helped increase mean prescription fill rates by 54% and materially decreased the mean interval between refills for one group of diabetic patients by 39%. The results were derived from a number of patient support programs conducted across a variety of chronic conditions, including diabetes, hypertension, acne and asthma/COPD.
HealthPrize's unique online and mobile platform leverages gaming dynamics, behavioral economics, rewards and education to motivate patients to engage with medical educational content and to adhere to their prescribed medications. The HealthPrize platform also verifies prescription fills for all engaged patients via a proprietary process that allows for real-time, accurate refill verification and adherence tracking.
"If you look at our engagement rates as compared to social media sites, the numbers are impressive," stated HealthPrize CEO Tom Kottler. "According to Comscore, 77% of Facebook members are active on a monthly basis; our hypertension patients were at 72%. The average LinkedIn user spends 17 minutes on their site per month; our Diabetes 2 group spent an average of 43 minutes monthly on web or mobile with HealthPrize, and across all programs the average user spent almost 37 minutes engaged with the platform each month."
Additionally, each week an average of 55% percent of patients also completed a new educational quiz and a market research survey, leading to rich data sets and valuable insights.
"We built our platform based on best practices leveraging gamification to maximize engagement and adherence within strict pharmaceutical industry regulations, and patients have responded fervently," said John Ragland, chief of product and user experience at HealthPrize. "We have yet to see results in the marketplace that match ours."